Efgartigimod Successful in Immune Thrombocytopenia
Efgartigimod significantly improved platelet counts in patients with primary immune...
Read MoreDec 14, 2022
Efgartigimod significantly improved platelet counts in patients with primary immune...
Read MoreDec 14, 2022
Talquetamab demonstrated a favorable safety profile and promising response rates in a heavily...
Read MoreDec 14, 2022
Triplet therapy of azacitidine, venetoclax, and magrolimab was safe as first-line therapy in...
Read MoreDec 14, 2022
A curated ebook of recent studies, findings, and thought leader perspectives from AHA 2022.
Read MoreDec 14, 2022
A quiz based on the latest NMOSD news and research from ECTRIMS.
Read MoreDec 14, 2022
“Too bad it was a typo. I was doing pretty well on the low-crab diet!”
Read MoreDec 13, 2022
Q: My partner and I (we are both family practitioners) have been offered the opportunity to be...
Read MoreDec 9, 2022
Almost one-third of residents with gout living in aged care facilities did not receive...
Read More